Following a global recall of infant formula products due to cereulide toxin contamination, EU officials are taking steps to prevent illnesses from cereulide-tainted formula in the future. Cases of mild illness associated with recalled product have been reported in Europe.
The scientific opinion was published to provide a scientific basis for possible amendments to existing requirements in EU legislation for food business operators on the freezing of meat.
The document clarifies key points about the scope of and compliance with Regulation (EU) 2024/3190, which bans the use of BPA and other hazardous bisphenols in food contact materials on the EU market.
New research has demonstrated that certain plant-based compounds (i.e., curcumin, berberine, quercetin, and capsaicin) can enhance the antimicrobial effect of blue light treatment against Listeria monocytogenes on food and disrupt its biofilm-forming abilities.
Researchers estimate that the use of whole genome sequencing (WGS) for routine pathogen surveillance in Australia prevents up to 10,900 foodborne salmonellosis cases and delivers as much as $17 million in cost savings annually.
Nofima recently reported on a successful “Seek and Destroy” process carried out by a smoked salmon producer implicated in a listeriosis outbreak, which demonstrated the importance of hygienic design and WGS, and the limitations of standard cleaning and sampling.
An analysis of a decade of antimicrobial resistance (AMR) surveillance data in foodborne pathogens (i.e., Salmonella, Campylobacter, and Escherichia coli) has identified patterns shaping multidrug resistance (MDR) in food animal production systems.
An international study has shown that European seafood is high in PFAS, and that fish exports expose consumers in regions of the world with otherwise low levels of pollution to harmful “forever chemicals.”
The guidance defines the scientific data required to evaluate if a food additive is safe under the proposed conditions of use as part of new food additive applications in the EU.
Nestlé says that cereulide, the contaminant behind the recall, does not cause meningitis, the illness for which the infant was hospitalized. UK authorities say no cases of illness associated with Nestlé formula have been clinically confirmed.